I have been in contact with Rising since early in 2023. Their initial release date was June of 2023, but keeps getting pushed back. Parent company is in India and they've had some issues meeting FDA specifications. I'm hoping their latest release forecast of Q1 2025 holds. I don't know for a fact that Chartwell is massively overcharging, but they are the only supplier of Flurazepam as of now. Competition is always a good thing.

I contacted the FDA and I get a monthly list of medication approvals. Checking every month for Rising. In the meantime, I'm preparing to grind my teeth and shell out 600 bucks for the next 30 days. Still better than no sleep for who knows how many nights.